TY - BOOK PY - 2013 DA - 2013// TI - IDF diabetes atlas, 6th edn. Brussels PB - International Diabetes Federation CY - Belgium ID - ref1 ER - TY - JOUR AU - Drucker, D. J. AU - Sherman, S. I. AU - Gorelick, F. S. AU - Bergenstal, R. M. AU - Sherwin, R. S. AU - Buse, J. B. PY - 2010 DA - 2010// TI - Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits JO - Diabetes Care VL - 33 UR - https://doi.org/10.2337/dc09-1499 DO - 10.2337/dc09-1499 ID - Drucker2010 ER - TY - JOUR AU - Deacon, C. F. AU - Lebovitz, H. E. PY - 2016 DA - 2016// TI - Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureas JO - Diabetes Obes Metab VL - 18 UR - https://doi.org/10.1111/dom.12610 DO - 10.1111/dom.12610 ID - Deacon2016 ER - TY - JOUR AU - Ahren, B. AU - Pacini, G. AU - Foley, J. E. AU - Schweizer, A. PY - 2005 DA - 2005// TI - Improved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year JO - Diabetes Care VL - 28 UR - https://doi.org/10.2337/diacare.28.8.1936 DO - 10.2337/diacare.28.8.1936 ID - Ahren2005 ER - TY - JOUR AU - Lyu, X. AU - Zhu, X. AU - Zhao, B. AU - Du, L. AU - Chen, D. AU - Wang, C. PY - 2017 DA - 2017// TI - Effects of dipeptidyl peptidase-4 inhibitors on beta-cell function and insulin resistance in type 2 diabetes: meta-analysis of randomized controlled trials JO - Sci Rep VL - 7 UR - https://doi.org/10.1038/srep44865 DO - 10.1038/srep44865 ID - Lyu2017 ER - TY - JOUR AU - Nonaka, K. AU - Kakikawa, T. AU - Sato, A. AU - Okuyama, K. AU - Fujimoto, G. AU - Kato, N. PY - 2008 DA - 2008// TI - Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes JO - Diabetes Res Clin Pract VL - 79 UR - https://doi.org/10.1016/j.diabres.2007.08.021 DO - 10.1016/j.diabres.2007.08.021 ID - Nonaka2008 ER - TY - JOUR AU - van Genugten, R. E. AU - van Raalte, D. H. AU - Diamant, M. PY - 2012 DA - 2012// TI - Dipeptidyl peptidase-4 inhibitors and preservation of pancreatic islet-cell function: a critical appraisal of the evidence JO - Diabetes Obes Metab VL - 14 UR - https://doi.org/10.1111/j.1463-1326.2011.01473.x DO - 10.1111/j.1463-1326.2011.01473.x ID - van Genugten2012 ER - TY - JOUR AU - Lamers, D. AU - Famulla, S. AU - Wronkowitz, N. AU - Hartwig, S. AU - Lehr, S. AU - Ouwens, D. M. PY - 2011 DA - 2011// TI - Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome JO - Diabetes VL - 60 UR - https://doi.org/10.2337/db10-1707 DO - 10.2337/db10-1707 ID - Lamers2011 ER - TY - JOUR AU - Derosa, G. AU - Carbone, A. AU - Franzetti, I. AU - Querci, F. AU - Fogari, E. AU - Bianchi, L. PY - 2012 DA - 2012// TI - Effects of a combination of sitagliptin plus metformin vs metformin monotherapy on glycemic control, beta-cell function and insulin resistance in type 2 diabetic patients JO - Diabetes Res Clin Pract VL - 98 UR - https://doi.org/10.1016/j.diabres.2012.05.022 DO - 10.1016/j.diabres.2012.05.022 ID - Derosa2012 ER - TY - JOUR AU - Derosa, G. AU - Ragonesi, P. D. AU - Carbone, A. AU - Fogari, E. AU - Bianchi, L. AU - Bonaventura, A. PY - 2012 DA - 2012// TI - Vildagliptin added to metformin on beta-cell function after a euglycemic hyperinsulinemic and hyperglycemic clamp in type 2 diabetes patients JO - Diabetes Technol Ther VL - 14 UR - https://doi.org/10.1089/dia.2011.0278 DO - 10.1089/dia.2011.0278 ID - Derosa2012 ER - TY - JOUR AU - Kern, M. AU - Kloting, N. AU - Niessen, H. G. AU - Thomas, L. AU - Stiller, D. AU - Mark, M. PY - 2012 DA - 2012// TI - Linagliptin improves insulin sensitivity and hepatic steatosis in diet-induced obesity JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0038744 DO - 10.1371/journal.pone.0038744 ID - Kern2012 ER - TY - JOUR AU - Muniyappa, R. AU - Lee, S. AU - Chen, H. AU - Quon, M. J. PY - 2008 DA - 2008// TI - Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage JO - Am J Physiol Endocrinol Metab VL - 294 UR - https://doi.org/10.1152/ajpendo.00645.2007 DO - 10.1152/ajpendo.00645.2007 ID - Muniyappa2008 ER - TY - JOUR AU - DeFronzo, R. A. AU - Tobin, J. D. AU - Andres, R. PY - 1979 DA - 1979// TI - Glucose clamp technique: a method for quantifying insulin secretion and resistance JO - Am J Phys VL - 237 ID - DeFronzo1979 ER - TY - JOUR AU - Levy, J. C. AU - Matthews, D. R. AU - Hermans, M. P. PY - 1998 DA - 1998// TI - Correct homeostasis model assessment (HOMA) evaluation uses the computer program JO - Diabetes Care VL - 21 UR - https://doi.org/10.2337/diacare.21.12.2191 DO - 10.2337/diacare.21.12.2191 ID - Levy1998 ER - TY - JOUR AU - Matthews, D. R. AU - Hosker, J. P. AU - Rudenski, A. S. AU - Naylor, B. A. AU - Treacher, D. F. AU - Turner, R. C. PY - 1985 DA - 1985// TI - Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man JO - Diabetologia VL - 28 UR - https://doi.org/10.1007/BF00280883 DO - 10.1007/BF00280883 ID - Matthews1985 ER - TY - JOUR AU - Hovorka, R. AU - Chassin, L. AU - Luzio, S. D. AU - Playle, R. AU - Owens, D. R. PY - 1998 DA - 1998// TI - Pancreatic beta-cell responsiveness during meal tolerance test: model assessment in normal subjects and subjects with newly diagnosed noninsulin-dependent diabetes mellitus JO - J Clin Endocrinol Metab VL - 83 ID - Hovorka1998 ER - TY - JOUR AU - Del Prato, S. AU - Barnett, A. H. AU - Huisman, H. AU - Neubacher, D. AU - Woerle, H. J. AU - Dugi, K. A. PY - 2011 DA - 2011// TI - Effect of linagliptin monotherapy on glycaemic control and markers of beta-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial JO - Diabetes Obes Metab VL - 13 UR - https://doi.org/10.1111/j.1463-1326.2010.01350.x DO - 10.1111/j.1463-1326.2010.01350.x ID - Del Prato2011 ER - TY - JOUR AU - Forst, T. AU - Uhlig-Laske, B. AU - Ring, A. AU - Graefe-Mody, U. AU - Friedrich, C. AU - Herbach, K. PY - 2010 DA - 2010// TI - Linagliptin (BI 1356), a potent and selective DPP-4 inhibitor, is safe and efficacious in combination with metformin in patients with inadequately controlled type 2 diabetes JO - Diabet Med VL - 27 UR - https://doi.org/10.1111/j.1464-5491.2010.03131.x DO - 10.1111/j.1464-5491.2010.03131.x ID - Forst2010 ER - TY - JOUR AU - Taskinen, M. R. AU - Rosenstock, J. AU - Tamminen, I. AU - Kubiak, R. AU - Patel, S. AU - Dugi, K. A. PY - 2011 DA - 2011// TI - Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study JO - Diabetes Obes Metab VL - 13 UR - https://doi.org/10.1111/j.1463-1326.2010.01326.x DO - 10.1111/j.1463-1326.2010.01326.x ID - Taskinen2011 ER - TY - JOUR AU - Flory, J. H. AU - Small, D. S. AU - Cassano, P. A. AU - Brillon, D. J. AU - Mushlin, A. I. AU - Hennessy, S. PY - 2014 DA - 2014// TI - Comparative effectiveness of oral diabetes drug combinations in reducing glycosylated hemoglobin JO - J Comp Eff Res VL - 3 UR - https://doi.org/10.2217/cer.13.87 DO - 10.2217/cer.13.87 ID - Flory2014 ER - TY - JOUR AU - Retnakaran, R. AU - Qi, Y. AU - Opsteen, C. AU - Vivero, E. AU - Zinman, B. PY - 2010 DA - 2010// TI - Initial short-term intensive insulin therapy as a strategy for evaluating the preservation of beta-cell function with oral antidiabetic medications: a pilot study with sitagliptin JO - Diabetes Obes Metab VL - 12 UR - https://doi.org/10.1111/j.1463-1326.2010.01254.x DO - 10.1111/j.1463-1326.2010.01254.x ID - Retnakaran2010 ER - TY - JOUR AU - Azuma, K. AU - Radikova, Z. AU - Mancino, J. AU - Toledo, F. G. AU - Thomas, E. AU - Kangani, C. PY - 2008 DA - 2008// TI - Measurements of islet function and glucose metabolism with the dipeptidyl peptidase 4 inhibitor vildagliptin in patients with type 2 diabetes JO - J Clin Endocrinol Metab VL - 93 UR - https://doi.org/10.1210/jc.2007-1369 DO - 10.1210/jc.2007-1369 ID - Azuma2008 ER - TY - JOUR AU - Dai, W. AU - Ye, L. AU - Liu, A. AU - Wen, S. W. AU - Deng, J. AU - Wu, X. PY - 2017 DA - 2017// TI - Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a meta-analysis JO - Medicine (Baltimore) VL - 96 UR - https://doi.org/10.1097/MD.0000000000008179 DO - 10.1097/MD.0000000000008179 ID - Dai2017 ER - TY - JOUR AU - Fierbinteanu-Braticevici, C. AU - Negreanu, L. PY - 2013 DA - 2013// TI - Tarantino G. Is fatty liver always benign and should not consequently be treated? JO - J Physiol Pharmacol VL - 64 ID - Fierbinteanu-Braticevici2013 ER - TY - JOUR AU - Portillo-Sanchez, P. AU - Bril, F. AU - Maximos, M. AU - Lomonaco, R. AU - Biernacki, D. AU - Orsak, B. PY - 2015 DA - 2015// TI - High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels JO - J Clin Endocrinol Metab VL - 100 UR - https://doi.org/10.1210/jc.2015-1966 DO - 10.1210/jc.2015-1966 ID - Portillo-Sanchez2015 ER - TY - JOUR AU - Mittendorfer, B. PY - 2005 DA - 2005// TI - Insulin resistance: sex matters JO - Curr Opin Clin Nutr Metab Care VL - 8 UR - https://doi.org/10.1097/01.mco.0000172574.64019.98 DO - 10.1097/01.mco.0000172574.64019.98 ID - Mittendorfer2005 ER - TY - JOUR AU - Karakelides, H. AU - Irving, B. A. AU - Short, K. R. AU - O'Brien, P. AU - Nair, K. S. PY - 2010 DA - 2010// TI - Age, obesity, and sex effects on insulin sensitivity and skeletal muscle mitochondrial function JO - Diabetes VL - 59 UR - https://doi.org/10.2337/db09-0591 DO - 10.2337/db09-0591 ID - Karakelides2010 ER - TY - JOUR AU - Magkos, F. AU - Wang, X. AU - Mittendorfer, B. PY - 2010 DA - 2010// TI - Metabolic actions of insulin in men and women JO - Nutrition VL - 26 UR - https://doi.org/10.1016/j.nut.2009.10.013 DO - 10.1016/j.nut.2009.10.013 ID - Magkos2010 ER -